title: Re: Pooled analysis of fluorouracil-based adjuvant therapy of stage II and III colon cancer: who benefits and by how much?
authors.forename: Hany
authors.initials: H
authors.lastname: Elsaleh
authors.forename: Barry
authors.initials: B
authors.lastname: Iacopetta
mesh_terms: D000367:Age Factors; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D019175:DNA Methylation; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D018895:Microsatellite Repeats; D010641:Phenotype; D015203:Reproducibility of Results; D012737:Sex Factors; D016019:Survival Analysis
chemical_list: D005472:Fluorouracil